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Edited by Sandro SonninoAbstract We investigated the interaction of oxidized low den-
sity lipoprotein (OxLDL) with the ATP-binding cassette A1
(ABCA1) pathway in J774 macrophages. Cellular eﬄux to apo-
lipoprotein AI (apo-AI) of OxLDL-derived cholesterol was low-
er than eﬄux of cholesterol derived from acetylated low density
lipoprotein (AcLDL). ABCA1 upregulation by 8-(4-chlorophe-
nylthio)adenosine 3 0:5 0-cyclic monophosphate (cpt-cAMP) or
22 (R)-hydroxycholesterol (22-OH) and 9-cis retinoic acid
(9cRA) increased the eﬄux to apo-AI of cellular sterols derived
from AcLDL, but not of those from OxLDL. AcLDL, but not
OxLDL, induced ABCA1 protein content and activity in J774.
However, OxLDL did not inﬂuence J774 ABCA1 upregulation
by cpt-cAMP or 22-OH/9cRA. We conclude that sterols re-
leased to cells by OxLDL are available neither as substrate
nor as modulator of ABCA1.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Foam cells1. Introduction
A number of evidences suggests a role for low density
lipoprotein (LDL) oxidation in the development of athero-
sclerosis. This includes the identiﬁcation of lipid oxidation
products in human and animal atheroma and plasma [1]
and the observation that various cells of the arterial intimaAbbreviations: ABCA1, ATP-binding cassette A1; AcLDL, acetylated
low density lipoprotein; apo-AI, apolipoprotein AI; BSA, bovine ser-
um albumin; 9cRA, 9-cis retinoic acid; cpt-cAMP, 8-(4-chlorophenyl-
thio)adenosine 3 0:50-cyclic monophosphate; CE, cholesteryl ester;
FCS, fetal calf serum; FC, free cholesterol; LDL, low density lipopr-
otein; 22-OH, 22 (R)-hydroxycholesterol; MPM, mouse peritoneal
macrophages; PBS, phosphate buﬀer saline; PMA, phorbol, 12-myri-
state, 13-acetate; OxLDL, oxidized low density lipoprotein; 7K, 7-
ketocholesterol
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regulate scavenger receptors and therefore the inﬂow of cho-
lesterol, removal (eﬄux) of excess cellular cholesterol from
these cells is of particular importance to prevent foam cell
formation [3]. Eﬄux of cellular cholesterol is a complex
and heterogeneous process promoted by many factors and
requiring the presence of extracellular cholesterol acceptors
[4].
ATP-binding cassette A1 (ABCA1) is crucial for the mobi-
lization of cholesterol from tissues via its interaction with
apolipoproteins or lipid-poor particles [5]; consistently
ABCA1 expression is upregulated by macrophages in athero-
sclerotic lesions, presumably in response to cholesterol
enrichment [6]. Consistently, ABCA1 gene expression is
highly responsive to liver-X-receptor (LXR) agonists, such
as 22-hydroxycholesterol (22-OH) and 27-hydroxycholesterol
in combination with retinoic-X-receptor (RXR) ligands such
as 9-cis-retinoic acid (9cRA) [7,8]. Expression of ABCA1 in
macrophages is also induced by cAMP stimulation and most
importantly by cholesterol enrichment [9,10].
Although it has been reported that oxidized low density
lipoprotein (OxLDL)-loaded cells release cholesterol less eﬃ-
ciently than do cells loaded with acetylated LDL (AcLDL)
[11], the impact of OxLDL on ABCA1-mediated pathway re-
mains to be clariﬁed. In the present study we investigated the
ABCA1-mediated eﬄux of sterols accumulated from OxLDL
in murine macrophages, as well as the eﬀect of OxLDL load-
ing on ABCA1 cellular function and content.2. Materials and methods
2.1. Materials
Fetal calf serum (FCS), bovine serum albumin (BSA), 3 0,5 0-cyclic
monophosphate (cpt-cAMP), 9cRA, 22-OH were purchased from
Sigma (St. Louis, MO, USA). Apo-AI was kindly donated by Dr.
Laura Calabresi (University of Milan). [1,2-3H]cholesterol and
[methyl-3H] -choline chloride were from Amersham Biosciences (Upp-
sala, Sweden). Rabbit-anti-mouse ABCA1 antibody was purchased
from Novus Biological (Cambridge, UK).
2.2. Lipoprotein preparation
Human LDL (d = 1.019–1.063 g/ml) were isolated from plasma of
healthy volunteers by sequential ultracentrifugation (Beckman L5-50,
Palo Alto, CA) [12]. LDL were acetylated according to Basu et al.
[13]. Chemical oxidation was performed under sterile condition, by
incubating LDL at 37C for 24 h, at 0.2 mg protein/ml phosphate buﬀerblished by Elsevier B.V. All rights reserved.
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addition of BHT 40 lM. Modiﬁcation of lipoproteins was tested by
non-denaturing gel electrophoresis [11]. AcLDL and OxLDLwere radi-
olabeled with [3H]-cholesteryl linoleate (Amersham, Buckinghamshire,
UK) by incubation with serum containing the cholesteryl ester (CE)
transfer protein [14]. Speciﬁc activity ranged from 711 to 1926 cpm/
lg protein for OxLDL and from 789 to 1637 cpm/lg protein for
AcLDL, respectively.2.3. Cell cultures
J774 mouse macrophages were cultured in RPMI1640 supplemented
with 10% FCS. Mouse peritoneal macrophages (MPM) were obtained
from peritoneum of Swiss mice as previously described [15] and were
plated in Dulbeccos minimum essential medium supplemented with
10% FCS. Human monocytes-derived macrophages THP-1 were cul-
tured in RPMI1640/HEPES supplemented with 1 mM Na pyruvate,
50 lM b-mercaptoethanol, 2.5 mg/ml glucose and 10% FCS. THP-1
diﬀerentiation was obtained adding 50 ng/ml phorbol, 12-myristate,
13-acetate (PMA).2.4. Sterol and phospholipid eﬄux
80% conﬂuent cells were [3H]sterol loaded by incubation with 30 lg/
ml [3H]-AcLDL or 30 lg/ml [3H]-OxLDL for 24 h in medium with
0.2% BSA. In separated experiments cellular cholesterol was radiola-
beled by adding 2–3 lCi/ml [1,2-3H]cholesterol in medium supple-
mented with 1% FCS and 30 lg/ml AcLDL or 30–60 lg/ml OxLDL
for 24–48 h. Eﬄux was promoted for 4–18 h by incubation with
20 lg/ml apolipoprotein AI (apo-AI) in a medium supplemented with
0.2% BSA and results corrected for eﬄux in absence of apo-AI. Time
zero (T0) cells wells were harvested before incubation with apo-AI. The
percent eﬄux of lipid was calculated as: (cpm in medium/cpm
To) · 100 [5].
Phospholipid eﬄux was evaluated in J774 labeled with 4 lCi/ml
[methyl-3H]choline chloride for 48 h in RPMI medium with 1% FCS
in the presence of 30 lg/ml AcLDL or 30 lg/ml OxLDL. After this
time cells were treated with 20 lg/ml apo-AI for 18 h in a medium sup-
plemented with 0.2% BSA. Eﬄux media were extracted by the Bligh
and Dyer method [16].2.5. Western blot analysis
Cell monolayers were lysed in 1% Triton X-100, 0.5% NP-40, 10 mM
tris buﬀer containing 10 lg/ml aprotinin, 1 lg/ml leupeptin, 1 lg/ml
pepstatin, 0.2 mM PMSF and homogenized through a 27-gauge nee-
dle. Protein were separated on 5% Tris–acetate gels and immunoblot-
ted with anti-ABCA1 polyclonal antibody.2.6. Analysis of ABCA1 mRNA by real time quantitative RT-PCR
Total RNA was prepared using NucleoSpin RNA II Flyer
(Macherey-Nagel) according to the instructions given by the manu-
facturer. Real time quantitative PCR analysis was used to determine
the levels of ABCA1 in J774 upon treatment with 30 lg/ml AcLDL
or OxLDL in medium supplemented with 0.2% BSA. Reverse tran-
scription and PCRs were performed according to the manufacturers
instructions (Applied Biosystems). Sequence-speciﬁc ampliﬁcation
was detected with an increasing ﬂuorescent signal of FAM (reporter
dye) during the ampliﬁcation cycle on an ABI Prism 7000 (Applied
Biosystems).Table 1
[3H]Sterol distribution in [3H] lipoproteins and in [3H] lipoprotein-
loaded J774 macrophages
CE FC Oxysterols2.7. [3H]-Sterol thin layer chromatography (TLC)
Cells and lipoproteins were extracted, respectively, by isopropanol
or chloroform:methanol (1:1). TLC was performed with a mobile
phase of 170 ml hexanes, 20 ml ethyl-ether and 10 ml methanol. The
recovery of TLC procedure ranged from 70% to 80%.Percent of total sterols in lipoproteins
[3H]-AcLDL 91.5 ± 3.1 4.2 ± 0.8 1.3 ± 0.3
[3H]-OxLDL 33.9 ± 1.5 30.7 ± 1.2 29.4 ± 1.1
Percent of total sterols in loaded cells
J774+[3H]-AcLDL 35.1 ± 2.1 58.1 ± 2.3 1.8 ± 0.3
J774+[3H]-OxLDL 14.3 ± 1.2 46.8 ± 1.6 33.9 ± 1.3
FC, cholesterol; CE, cholesteryl esters.2.8. Intracellular cholesterol mass
Macrophages were incubated for 32 h with either AcLDL (30 lg/ml)
or OxLDL (30–60 lg/ml) in RPMI supplemented with 1% FCS. Lipids
were extracted from the washed monolayers with hexane: isopropanol
(3:2, v/v). Total cholesterol was determinated following the instruc-
tions of Cholesterol Clonital Kit (Amplimedical). Cellular proteins
were quantitated according to Lowry assay.2.9. Statistical analysis
Results were presented as means ± S.D. of data obtained from trip-
licate wells. Signiﬁcant diﬀerences were established by Students t-test
using Graph Pad Prism (GraphPad Software, Inc).3. Results
3.1. Cellular eﬄux of sterols derived from [3H]-AcLDL or
[3H]-OxLDL
TLC analysis indicated that more than 90% of radioactivity
was present as CE in [3H]-AcLDL, while in [3H]-OxLDL the
radioactivity was equally distributed among CE, free choles-
terol (FC) and a fraction that migrate as standard 7-ketocho-
lesterol (7K) (Table 1). Calculations based on speciﬁc activity
indicate that the amounts of [3H]-sterols incorporated by cells
were 66.16 ± 7.4 and 79.33 ± 5.9 lg/mg after 24 h incubation
with either 30 lg/ml of [3H]-AcLDL or [3H]-OxLDL respec-
tively, indicating no diﬀerence in total [3H]-sterol cellular up-
take. About 90% of total radioactive sterols of cells
incubated with [3H]-AcLDL was associated with cholesterol.
In [3H]-OxLDL-loaded cells cholesterol represented 70% and
30% of radioactivity migrated with 7K (Table 1). Colorimetric
enzymatic assay indicated that cellular sterol mass increased
from 85.9 to 139.5 lg/mg and 130.9 lg/mg after incubation
with 30 lg/ml AcLDL or 30 lg/mg OxLDL, respectively.
Eﬄux experiments indicate that [3H]-OxLDL-loaded cells
released less sterols to apo-AI than cells incubated with [3H]-
AcLDL (Fig. 1). In [3H]-AcLDL loaded cells, induction of
ABCA1 by cpt-cAMP or 22-OH/9cRA increased the percent
of [3H]-sterol eﬄux to apo-AI by about 2- and 3-fold, respec-
tively. The same treatments failed to stimulate radioactivity re-
lease in cell exposed to [3H]-OxLDL (Fig. 1). Conﬁrmatory
results were observed in MPM. The [3H]-sterol eﬄux evaluated
in MPM treated with 22-OH/9cRA increased 2.9 times in [3H]-
AcLDL and only 1.2 in [3H]-OxLDL loaded cells.
3.2. Eﬀect of AcLDL or OxLDL on cellular ABCA1 activity
and expression
AcLDL loading increased phospholipid eﬄux from J774 by
about 4-fold, while none stimulatory eﬀect was observed upon
OxLDL treatment (Fig. 2A). Similarly to phospholipid, cho-
lesterol eﬄux to apoA-I was induced by incubation of cells
with AcLDL, but not with OxLDL (Fig. 2B). Similar results
were obtained evaluating cholesterol eﬄux after a shorter incu-
bation time with apo A-I. The eﬄux to apo A-I after 4 h was
1.2% ± 0.08, 2.2% ± 0.27 and 1.3% ± 0.14 in control, AcLDL
and OxLDL pre-treated cells, respectively.
Fig. 1. Eﬄux of [3H]-sterols from [3H]-AcLDL or [3H]-OxLDL-loaded
J774. Cell monolayers were incubated with 30 lg/ml [3H]-AcLDL or
30 lg/ml [3H]-OxLDL for 24 h in RPMI medium containing 0.2%
BSA. 20 lg/ml apo-AI was added with or without 0.3 mM cpt-cAMP
or 5 lg/ml 22-OH and 10 lM 9cRA for 18 h. Data are from a
representative experiment of four with triplicate wells (n = 3). Values
are expressed as means ± S.D. *P < 0.001, **P < 0.0001 compared with
apo-AI alone.
Fig. 2. Eﬄux of phospholipids and cholesterol to apo-AI from
AcLDL or OxLDL-loaded J774 under basal condition. Cells were
labeled with either 4 lCi/ml [methyl-3H]-choline chloride for 48 h (A)
or 3 lCi/ml [3H]-cholesterol for 24 h (B) in RPMI medium plus 1%
FCS in the presence of 30 lg/ml AcLDL or 30 lg/ml OxLDL. After
this time cells 20 lg/ml apo-AI were added for 18 h. Data are from a
representative experiment of six with triplicate wells (n = 3). Values are
expressed as means ± S.D. *P < 0.0001, compared with control, (A)
and (B).
Fig. 3. Eﬄux of phospholipids to apo-AI from AcLDL or OxLDL-
loaded J774 expressing ABCA1. J774 macrophages were labeled with
4 lCi/ml [methyl-3H]-choline chloride for 48 h in RPMI medium with
1% FCS in the presence of 30 lg/ml AcLDL or 30 lg/ml OxLDL.
After this time cells were treated with 20 lg/ml apo-AI in the presence
or absence of either 0.3 mM cpt-cAMP (A) or 5 lg/ml 22-OH and
10 lM 9cRA (B) for 18 h. Data are from a representative experiment
of three with triplicate wells (n = 3). Values are expressed as
means ± S.D. *P < 0.0001, compared with cpt-cAMP alone (A) or
22-OH/9cRA alone (B).
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phospholipid eﬄux in cells expressing ABCA1 upon stimula-
tion by cpt-cAMP (Fig. 3A) or by 22-OH/9cRA (Fig. 3B).
Phospholipid eﬄux was not aﬀected by OxLDL and was fur-
ther stimulated by AcLDL. Similar results were obtained eval-
uating cholesterol eﬄux (data not shown). To evaluate
whether the inability of OxLDL to inﬂuence lipid eﬄux could
depend on time of incubation with cells we performed a time
course experiment. As depicted, throughout the incubation
times with the modiﬁed lipoproteins, cholesterol eﬄux to
apoA-I was induced by incubation of cells with AcLDL, but
not with OxLDL (Fig. 4). Similar results were obtained with
an higher concentration of OxLDL (60 lg/ml) (data not
shown). In MPM and in human THP-1 after 48 h of incuba-
tion with modiﬁed lipoproteins cholesterol eﬄux increased al-
most 2 times in AcLDL loaded cells and was unchanged
following OxLDL loading (Fig. 5).
Accordingly to the results on lipid eﬄux, in J774 cells
AcLDL and not OxLDL loading induced ABCA1 expression
while cpt-cAMP treatment increased the ABCA1 protein levelsin the presence of both modiﬁed LDL (Fig. 6). Consistently,
mRNA levels of ABCA1 in J774 were increased by about 2-
fold by incubation with AcLDL but not by OxLDL (Fig. 7).4. Discussion
OxLDL have a defective cellular catabolism [17] that include
a reduced capacity of OxLDL-loaded macrophages to eﬄux
their cholesterol and oxysterol content to an extracellular
acceptor [11,18]. One of the major pathway of cholesterol re-
lease from macrophages involves the process of lipid eﬄux
mediated by ABCA1, however no information is available
on OxLDL and ABCA1 pathway interactions. Purposes of
the present study were: (1) to investigate in cultured macro-
phages the eﬀect of stimulation of ABCA1 activity on cellular
eﬄux of sterols derived from OxLDL; (2) to evaluate in the
same cells the eﬀect of OxLDL on cellular ABCA1 expression
and activity.
For the ﬁrst aim LDL were labeled with [3H]-CE and subse-
quently either acetylated or copper-oxidized. As previously de-
scribed, 24 h copper modiﬁcation of LDL was appropriate for
comparison with AcLDL [19]. As reported by others [11,20], in
our present study the amount of sterols released to cells was
Fig. 4. Cholesterol eﬄux to apo-AI in J774 exposed to AcLDL or
OxLDL for increasing periods of time. Monolayers were labeled with
2 lCi/ml [3H]-cholesterol in RPMI medium plus 1% FCS in the
presence of 30 lg/ml AcLDL or 30 lg/ml OxLDL for 24, 32 and 48 h.
Cells were then incubated for 18 h with RPMI containing 20 lg/ml
lipid free apo-AI. Data are from a representative experiment of three
with triplicate wells (n = 3). Values are expressed as means ± S.D.
*P < 0.0001, compared with control cells.
Fig. 5. Eﬄux of cholesterol to apo-AI from AcLDL or OxLDL-
loaded MPM or THP-1. THP-1 were treated with 50 ng/ml of PMA
for 72 h. Monolayers were then labeled with 2 lCi/ml [3H]-cholesterol
for 48 h in RPMI medium plus 1% FCS in the presence of AcLDL or
OxLDL. Cells were then incubated for 18 h with RPMI containing
20 lg/ml lipid free apo-AI. Data are from a representative experiment
of four with triplicate wells (n = 3). Values are expressed as
means ± S.D. *P < 0.0001, **P < 0.001 compared with control cells.
Fig. 6. ABCA1 protein expression in AcLDL or OxLDL-loaded J774
macrophages. J774 macrophages were treated with RPMI + 0.2% BSA
alone, in the presence of 30 lg/ml AcLDL or OxLDL. After 24 h cells
were incubated in the presence or absence of 0.3 mM cpt-cAMP. After
this incubation cells were washed with PBS and solubilized for Western
blot analysis as described in Section 2.
Fig. 7. ABCA1 mRNA levels in AcLDL or OxLDL-loaded J774
macrophages. Cells were treated as described on Fig. 5. After this
incubation cells were washed with PBS and solubilized for RT-PCR
analysis as described in Section 2. Values are expressed as
means ± S.D. *P < 0.05, **P < 0.01 compared with control cells.
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oxidation procedure induced the appearance of 30% of [3H]-
sterols that migrate in the TLC as standard 7K and an other
30% that migrate as standard FC. These results are completelyconsistent with those reported by Kritharides showing by high
performance liquid chromatography (HPLC) that about 30%
of sterols content in their OxLDL preparation was constituted
by 7K and an other 30% by FC [11,21]. Analysis of [3H]-sterol
content of cells incubated with our preparation of [3H]-
OxLDL indicated that only 15% of cholesterol was in the ester-
iﬁed form. This result is in agreement with previous studies
showing that CE released to macrophages by OxLDL could
be hydrolyzed, but not esteriﬁed in these cells [22].
Stimulation of the ABCA1 pathway in macrophages could
induce the release of sterols derived from [3H]-AcLDL, but
not those from [3H]-OxLDL. 7K is not substrate for eﬄux to
apoA-I [23,24], this might explain the lack of increase in
ABCA1-mediated sterol eﬄux derived from OxLDL in our
experiments. However, since stimulation of ABCA1 did not
produce any increase of eﬄux of radioactive sterols, we must
conclude that also the portion of radioactive cholesterol deliv-
ered to cells by OxLDL was not available for ABCA1.
For the second aim we tested the eﬀect of unlabeled OxLDL
or AcLDL on ABCAI expression and activity in the J774 mac-
rophages. Our results indicate that AcLDL could stimulate
ABCA1 expression as well as phospholipid and cholesterol ef-
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tion, consequently phospholipid and cholesterol eﬄux to
apo-AI was higher in AcLDL-loaded cells than in cells exposed
to OxLDL. The apparent discordance between relative mRNA
and protein level in our experiments (see Figs. 6 and 7) has
been previously reported and it may involve a post-transcrip-
tional regulation of ABCA1 expression [25]. The lack of ability
of OxLDL to stimulate ABCA1 was not overcome by increas-
ing the period of incubation with cells. These results might in-
volve at least two mechanisms: ﬁrst, cholesterol delivered by
OxLDL is not suﬃcient or available for ABCA1 upregulation;
second, the oxysterols present in these lipoproteins may exert
an inhibitory eﬀect on the ABCA1 pathway. The second
hypothesis is in contrast with our results showing that OxLDL
do not inhibit ABCA1 expression and activity induced in J774
by cpt-cAMP or 22-OH/9cRA. Gelissent et al. [24] reported
that 7K cholesterol may reduce apo-AI mediated eﬄux, there-
fore, one would have expected an inhibitory eﬀect on ABCA1
in our experimental conditions. However, in Gelissent work
7K was delivered to cells by 7K-enriched AcLDL [24]. Our
present results suggest that OxLDL release cholesterol and
oxysterols to cellular pools with a limited ability to modulate
cell lipid metabolism, including ABCA1 activity. Consistently,
it was demonstrated that OxLDL are trapped in an endolysos-
omial compartment and the released cholesterol was not avail-
able for esteriﬁcation [18]. A reduced cholesterol eﬄux to apo-
AI in OxLDL-loaded cells, as compared to cells exposed to
AcLDL, has been previously reported by Kritharides et al.
[11] in resident MPM. We suggest that this diﬀerence in choles-
terol eﬄux may be explained, at least in part, by the ability of
AcLDL, but not of OxLDL, to upregulate the ABCA1 path-
way. Our results in J774 were conﬁrmed evaluating the eﬀect
of OxLDL on cholesterol eﬄux in MPM and in THP-1 cells.
In the latter cellular models stimulation of ABCA1 expression
by OxLDL has been previously reported [26]. We do not have
an obvious explanation for this apparent discrepancy, however
it could be related to a diﬀerent extent of cell diﬀerentiation.
In conclusion we demonstrated that ABCA1 stimulation
fails to induce eﬄux of cholesterol released to cells by OxLDL.
In addition we showed that OxLDL do not modify cellular
ABCA1 protein expression. These functional impairments
may amplify the atherogenic potential of OxLDL.
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